Bepotastine Besilate

  Cat. No.:  DCAPI1500   Featured
Chemical Structure
190786-44-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist.
Cas No.: 190786-44-8
Chemical Name: Bepotastine besilate
Synonyms: Bepotastine besilate;(+)-(S)-4-[4-[1-(4-Chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid benzenesulfonate;1-Piperidinebutanoic acid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-, benzenesulfonate;benzenesulfonic acid,4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid;Bepotastine (Beslilate);Bepotastine Besylate;Bepotastine benzenesulfonate;Bepreve;Betotastine besilate;Talion;TAU-284;UNII-6W18MO1QR3;TAU 284;Talion (TN);Bepotastine Beslilat;Bepotastine Beslilate;Benzenesulfonate salt;Bepotastine besylate [USAN];6W18MO1QR3;4-((4-Chlorophenyl)-2-pyridinylmethoxy)- (S)-1-piperidinebutanoic acid monobenzenesulfonate;(+)-(S)-4-(4-((4-Chlorophenyl)(2-pyridyl)methoxy)piperidino)butyric acid monobenzenesulfonate;4-{4-[(s)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}buta
SMILES: ClC1C([H])=C([H])C(=C([H])C=1[H])[C@@]([H])(C1=C([H])C([H])=C([H])C([H])=N1)OC1([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])C(=O)O[H])C([H])([H])C1([H])[H].S(C1C([H])=C([H])C([H])=C([H])C=1[H])(=O)(=O)O[H]
Formula: C27H31ClN2O6S
M.Wt: 547.0628
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC70655 NLX-204 NLX-204 is a potent and selective ERK1/2 phosphorylation-preferring serotonin 5 HT1A receptor agonist with pKi = 10.19. NLX-204 displayed high selectivity in the SafetyScreen44 panel (including hERG channel), high solubility, metabolic stability, and Caco-2 penetration and did not block CYP3A4, CYP2D6 isoenzymes, or P-glycoprotein. Preliminary in vivo studies confirmed its promising pharmacokinetic profile. NLX-204 also robustly stimulated ERK1/2 phosphorylation in rat cortex and showed highly potent (MED = 0.16 mg/kg) and efficacious antidepressant-like activity, totally eliminating immobility in the rat Porsolt test.
DC10136 VUF10460 VUF10460 is a non-imidazole histamine H4 receptor agonist; binds to rat H4 receptor with a pKi of 7.46.
DC11271 S38093 HCl S 38093 is a novel brain-penetrant antagonist/inverse agonist of H3 receptors.
DC9465 Pitolisant (hydrochloride) Pitolisant Hcl(BF2.649;Ciproxidine ) is a novel, potent, and selective nonimidazole inverse agonist at the recombinant human H3 receptor (Ki=0.16 nM).
DC8773 JNJ-7777120 JNJ-7777120 is a selective H4R antagonist with Ki of 4 ±1 nM, exhibits >1000-fold selectivity over the other histamin receptors.
DC10102 GSK189254A GSK189254A (GSK189254) is a novel, potent and selective histamine H3 receptor antagonist with pKi values of 9.59-9.90 and 8.51-9.17 for human and rat H3, respectively.
DC7995 Bilastine Bilastine is a selective histamine H1 receptor antagonist used for treatment of allergic rhinoconjunctivitis and urticaria.
DCAPI1500 Bepotastine Besilate Bepotastine Beslilate (Bepreve) is a histamine H1 receptor anatagonist.
X